drugset / Trial / NCT00470249

Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT00470249 ↗

Phase 2 Terminated 5 enrolled University of Southampton
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as carboplatin and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving carboplatin together with gemcitabine works in treating patients with locally advanced or metastatic breast cancer.

Timeline

Start
2006-07-15
Primary completion
2008-11-03
Completion
2008-11-03

Outcome

Outcome not reported

Stopped (Enrollment): “Due to difficulty in recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Gemcitabine Small molecule 1500 mg/m2 Intravenous

Indications